Biomerica (NASDAQ: BMRA) CEO Zack Irani-Cohen sat down with Proactive's Steve Darling at the 12th annual LD Micro Conference in Bel Air, California. The Irvine, California-based company develops, manufactures, and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. Biomerica also has developed its patented InFoods product to treat irritable bowel syndrome and other gastrointestinal diseases.
Biomerica seeing their colorectal cancer screening test as a game changer
Quick facts: Biomerica, Inc.
Price: 7.1 USD
Market Cap: $83.44 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE